ArticlePLoS pathogens2018

Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap.

Philipp A Ilinykh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.